Accumulating evidence demonstrates that berberine not only reduces blood glucose by modulating key processes in glucose metabolism—including promoting glycogen synthesis, inhibiting gluconeogenesis, and enhancing glucose uptake—but also fundamentally alleviates insulin resistance through precise regulation of insulin signaling pathways, AMPK-mediated energy sensing, epigenetic modifications [18,211,212,213]. Here, INS is linked to Insulin resistance.